$10 Million Available to Support Innovative Cancer Research Projects
PHILADELPHIA — The American Association for Cancer Research calls upon the cancer research community to submit Letters of Intent for Stand Up To Cancer’s Innovative Research Grants (IRG), which support the next generation of extraordinary cancer research leaders in their quest to conquer cancer.
The grants will provide funding of up to $750,000 over a three-year period.
IRGs offer financial support to scientists pursuing novel, high-risk, but potentially high-reward cancer research proposals that have significant potential for translational application and hold great promise for advancing SU2C’s overarching goal of improving and saving lives. Proposals may focus on any discipline within basic, translational or clinical research, provided that these criteria are met.
Those interested should submit Letters of Intent detailing their best ideas for cutting-edge research projects on all forms of cancer, using the proposal website which can be found at: https://proposalcentral.altum.com.
The IRG Letters of Intent submission deadline is 12:00 p.m. ET on Monday, Nov. 15, 2010.
The SU2C Scientific Advisory Committee will review each Letter of Intent, at which point finalists will be selected to submit full research proposals.
The Innovative Research Grants program was established in honor of the late Judah Folkman, M.D., to recognize him as one of the great innovators in cancer research, an outstanding teacher of young investigators, and an early contributor to the SU2C project.
Since the launch of Stand Up To Cancer in 2008, the AACR has played an integral role as SU2C’s sole scientific partner by providing scientific leadership, expert peer review and grants administration. The AACR is responsible for administering these grants and, through the Scientific Advisory Committee and Innovative Research Grants Committee, provides ongoing scientific oversight to ensure that progress is being made.
The Scientific Advisory Committee is chaired by Nobel Laureate Phillip A. Sharp, Ph.D. The Innovative Research Grants Committee is chaired by Richard D. Kolodner, Ph.D., along with Vice-chairpersons William G. Kaelin Jr., M.D., and William G. Nelson, M.D., Ph.D. This prestigious committee conducts a unique, interactive, rapid and rigorous evaluation of the IRG applications via a multi-step scientific review process.
IRG recipients will be announced in April, 2011.
For general information on eligibility criteria, the nomination process and other details about the Innovative Research Grants, please visit: www.aacr.org/IRG. Or direct your inquiries to the SU2C Grants Office at: (267) 765-1049 or firstname.lastname@example.org.
# # #
About the American Association for Cancer Research
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists, providing a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
About Stand Up To Cancer
Stand Up To Cancer (SU2C) — a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization — raises funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives. SU2C facilitates collaboration among the best and the brightest in the cancer research community. By galvanizing the entertainment industry, SU2C generates awareness and builds grassroots support for this effort.
About the Entertainment Industry Foundation
Stand Up To Cancer is a program of the Entertainment Industry Foundation (EIF), the 501(c)(3) not-for-profit organization that serves as the collective philanthropy for the television and film businesses. EIF has distributed hundreds of millions of dollars to support programs addressing critical health, education and social issues.